Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
2
×
life sciences
national blog main
national top stories
sarepta therapeutics
alnylam pharmaceuticals
ambys medicines
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
athenex
biomarin pharmaceutical
biopharma
biotech
bluebird bio
boston
boulder/denver blog main
boulder/denver top stories
centers for medicare & medicaid services
chris collins
clinical trials
competitive generic therapy
cystic fibrosis
detroit blog main
detroit top stories
duchenne
europe blog main
europe top stories
fda
gene therapy
gout
hemophilia
indiana blog main
indiana top stories
innate immunotherapeutics
ironwood pharmaceuticals
kyowa hakko kirin
lacerta therapeutics
What
fda
2
×
gene
therapy
2
×
approval
aren’t
betting
billion
bio
biopharma
deal
developers
drug
drugs
duchenne
help
historic
imminent
long
medicare
medicine
moves
news
noteworthy
patients
prices
puts
recently
rna
road
roche
roundup
rulings
sarepta
second
separate
swiss
therapeutics
they’ll
winding
won
Language
unset
Current search:
therapy
×
deals
×
fda
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More